[{"Assets_0_Q2_USD":3708004000.0,"CommonStockSharesOutstanding_0_Q2_shares":186085864.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":147436000.0,"NetIncomeLoss_1_Q2_USD":-5120000.0,"NetIncomeLoss_2_Q2_USD":-37983000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":185327383.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":178866391.0,"StockholdersEquity_0_Q2_USD":1520873000.0,"Ticker":"HZNP","CIK":"1492426","name":"HORIZON THERAPEUTICS PUBLIC LTD CO","OfficialName":"Horizon Therapeutics Public Limited Company Ordinary Shares","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"26299872538.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190807"}]